Guinea vs Nepal: Access to anti-retroviral drugs, female
Guinea
83.0%
in 2024
Nepal
83.0%
in 2024
Guinea rank
53rd
Nepal rank
53rd
Access to anti-retroviral drugs, female over time
- Guinea
- Nepal
How they compare
Guinea currently reports 83.0% against 83.0% in Nepal, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Nepal ahead.
Guinea ranks 53rd and Nepal ranks 53rd of 141 countries.
Across the 3 decades both report, Guinea averaged higher in 1 and Nepal in 2.
Head to head by decade
| Decade | Guinea | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 2.8% | 0.9% | Guinea |
| 2010s | 32.7% | 35.5% | 2.8% | Nepal |
| 2020s | 70.2% | 72.8% | 2.6% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Guinea or Nepal?
- Guinea, at 83.0% against 83.0% in Nepal as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Guinea and Nepal?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Nepal?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea and Nepal rank globally for access to anti-retroviral drugs, female?
- Guinea ranks 53rd and Nepal ranks 53rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.